Ikena Oncology. has filed a patent for MEK inhibitors, compositions, and methods of use. The claim specifies a compound selection. GlobalData’s report on Ikena Oncology gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Ikena Oncology Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Ikena Oncology, Cancer treatment biomarkers was a key innovation area identified from patents. Ikena Oncology's grant share as of January 2024 was 10%. Grant share is based on the ratio of number of grants to total number of patents.

A recently filed patent (Publication Number: US20230382863A1) includes a series of claims related to compounds and pharmaceutical compositions. The claims outline the selection of specific compounds and their use in pharmaceutical compositions. The compounds mentioned in the claims are further specified in subsequent claims, detailing their potential applications and compositions.

The patent claims cover a range of compounds and pharmaceutical compositions, highlighting their potential in various applications. The compounds selected from the list provided are intended for use in pharmaceutical compositions, indicating a focus on their medicinal properties. The detailed nature of the claims suggests a specific and targeted approach to the development and utilization of these compounds in the pharmaceutical industry. Further research and development in this area could lead to the creation of novel drugs and treatments based on the compounds outlined in the patent claims.

To know more about GlobalData’s detailed insights on Ikena Oncology, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies